In October a trio of pharma-funded groups — the Alliance for Aging Research, USAgainstAlzheimer’s, and the Partnership to Fight Chronic Disease — released a poll showing strong support for ...
They also have to request the drug. The move has been hailed as “courageous action” by the lobby group USAgainstAlzheimer’s, which has been pushing for access to amyloid-targeting therapies ...